The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor
Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified tra...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 1998-07, Vol.77 (1), p.128-137 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 137 |
---|---|
container_issue | 1 |
container_start_page | 128 |
container_title | International journal of cancer |
container_volume | 77 |
creator | Watabe, Tetsuya Yoshida, Koichi Shindoh, Masanobu Kaya, Mitsunori Fujikawa, Keiko Sato, Hiroshi Seiki, Motoharu Ishii, Seiichi Fujinaga, Kei |
description | Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79950316</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79950316</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</originalsourceid><addsrcrecordid>eNqFkc1u1DAUhSMEKtPCIyB5gVC7yHDt_DgeEFUVCgRVmgVFsLtyHKc1ZOJgZ1p1xyPwErwYT4JnJswGJFbXvj73-NhfFJ1SmFMA9vz4Q1VWJxQEj4HR7JgKUQCH5ITzBX1JWbFYnFWv4-p9yeBVMod5uXzBYnEvmu1n7kez4AQxp0n-MDr0_gsApRmkB9GByBORQjqLfl5ea3I--l_ff1Ai-2ZaMzI62XvlzDAa25NWqtE6T0IxN3LUZAxjg7MrO-rQbq0jpr-RPmjDtPTeKhNkDVk7-9X00uutubJdJ6_0dh-K9mGKOO0H24fOaIkeTKPdSnbkytnb8Xq6-FH0oJWd14-nehR9fHN-Wb6LL5Zvq_LsIlZZSiGWad7WTS0a3jKaZ4WEhvEaNNeF4nUj25YXKtWqgYK2itZcJwIK2RQyfC_NsuQoerbzDU_7ttZ-xJXxSofQvbZrj1yIDBKaB-GnnVA5673TLQ7OrKS7Qwq4AYi4AYgbGLiBgX8AIudIMQBEDABxCxATBCyXyFAE5ydThHW90s3edyIWzp9O59Ir2bUBkzJ-L2Msh1RAkH3eyW5Np-_-SvffcP_KtmskvwG0MMoN</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79950316</pqid></control><display><type>article</type><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><source>Wiley-Blackwell Journals</source><source>MEDLINE</source><source>EZB Electronic Journals Library</source><creator>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</creator><creatorcontrib>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</creatorcontrib><description>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9</identifier><identifier>PMID: 9639404</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; Collagenases - genetics ; Dissemination ; DNA-Binding Proteins ; Epidermal Growth Factor - pharmacology ; Female ; Gene Expression Regulation, Neoplastic - drug effects ; Humans ; Medical sciences ; Neoplasm Invasiveness ; Promoter Regions, Genetic ; Proto-Oncogene Protein c-ets-1 ; Proto-Oncogene Protein c-ets-2 ; Proto-Oncogene Proteins - genetics ; Proto-Oncogene Proteins c-ets ; Repressor Proteins ; Trans-Activators - genetics ; Transcription Factors - genetics ; Tumor cell ; Tumor Cells, Cultured ; Tumors ; Urokinase-Type Plasminogen Activator - genetics</subject><ispartof>International journal of cancer, 1998-07, Vol.77 (1), p.128-137</ispartof><rights>Copyright © 1998 Wiley‐Liss, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C128%3A%3AAID-IJC20%3E3.0.CO%3B2-9$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0215%2819980703%2977%3A1%3C128%3A%3AAID-IJC20%3E3.0.CO%3B2-9$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2260490$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9639404$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watabe, Tetsuya</creatorcontrib><creatorcontrib>Yoshida, Koichi</creatorcontrib><creatorcontrib>Shindoh, Masanobu</creatorcontrib><creatorcontrib>Kaya, Mitsunori</creatorcontrib><creatorcontrib>Fujikawa, Keiko</creatorcontrib><creatorcontrib>Sato, Hiroshi</creatorcontrib><creatorcontrib>Seiki, Motoharu</creatorcontrib><creatorcontrib>Ishii, Seiichi</creatorcontrib><creatorcontrib>Fujinaga, Kei</creatorcontrib><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - pathology</subject><subject>Collagenases - genetics</subject><subject>Dissemination</subject><subject>DNA-Binding Proteins</subject><subject>Epidermal Growth Factor - pharmacology</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic - drug effects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Neoplasm Invasiveness</subject><subject>Promoter Regions, Genetic</subject><subject>Proto-Oncogene Protein c-ets-1</subject><subject>Proto-Oncogene Protein c-ets-2</subject><subject>Proto-Oncogene Proteins - genetics</subject><subject>Proto-Oncogene Proteins c-ets</subject><subject>Repressor Proteins</subject><subject>Trans-Activators - genetics</subject><subject>Transcription Factors - genetics</subject><subject>Tumor cell</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors</subject><subject>Urokinase-Type Plasminogen Activator - genetics</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1u1DAUhSMEKtPCIyB5gVC7yHDt_DgeEFUVCgRVmgVFsLtyHKc1ZOJgZ1p1xyPwErwYT4JnJswGJFbXvj73-NhfFJ1SmFMA9vz4Q1VWJxQEj4HR7JgKUQCH5ITzBX1JWbFYnFWv4-p9yeBVMod5uXzBYnEvmu1n7kez4AQxp0n-MDr0_gsApRmkB9GByBORQjqLfl5ea3I--l_ff1Ai-2ZaMzI62XvlzDAa25NWqtE6T0IxN3LUZAxjg7MrO-rQbq0jpr-RPmjDtPTeKhNkDVk7-9X00uutubJdJ6_0dh-K9mGKOO0H24fOaIkeTKPdSnbkytnb8Xq6-FH0oJWd14-nehR9fHN-Wb6LL5Zvq_LsIlZZSiGWad7WTS0a3jKaZ4WEhvEaNNeF4nUj25YXKtWqgYK2itZcJwIK2RQyfC_NsuQoerbzDU_7ttZ-xJXxSofQvbZrj1yIDBKaB-GnnVA5673TLQ7OrKS7Qwq4AYi4AYgbGLiBgX8AIudIMQBEDABxCxATBCyXyFAE5ydThHW90s3edyIWzp9O59Ir2bUBkzJ-L2Msh1RAkH3eyW5Np-_-SvffcP_KtmskvwG0MMoN</recordid><startdate>19980703</startdate><enddate>19980703</enddate><creator>Watabe, Tetsuya</creator><creator>Yoshida, Koichi</creator><creator>Shindoh, Masanobu</creator><creator>Kaya, Mitsunori</creator><creator>Fujikawa, Keiko</creator><creator>Sato, Hiroshi</creator><creator>Seiki, Motoharu</creator><creator>Ishii, Seiichi</creator><creator>Fujinaga, Kei</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19980703</creationdate><title>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</title><author>Watabe, Tetsuya ; Yoshida, Koichi ; Shindoh, Masanobu ; Kaya, Mitsunori ; Fujikawa, Keiko ; Sato, Hiroshi ; Seiki, Motoharu ; Ishii, Seiichi ; Fujinaga, Kei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5410-a46fbdb9d7f21658a0d27b0e7e8c7bdaff78c4ecd081fc1b7e3908ad8a1991553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Biological and medical sciences</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - pathology</topic><topic>Collagenases - genetics</topic><topic>Dissemination</topic><topic>DNA-Binding Proteins</topic><topic>Epidermal Growth Factor - pharmacology</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic - drug effects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Neoplasm Invasiveness</topic><topic>Promoter Regions, Genetic</topic><topic>Proto-Oncogene Protein c-ets-1</topic><topic>Proto-Oncogene Protein c-ets-2</topic><topic>Proto-Oncogene Proteins - genetics</topic><topic>Proto-Oncogene Proteins c-ets</topic><topic>Repressor Proteins</topic><topic>Trans-Activators - genetics</topic><topic>Transcription Factors - genetics</topic><topic>Tumor cell</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors</topic><topic>Urokinase-Type Plasminogen Activator - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watabe, Tetsuya</creatorcontrib><creatorcontrib>Yoshida, Koichi</creatorcontrib><creatorcontrib>Shindoh, Masanobu</creatorcontrib><creatorcontrib>Kaya, Mitsunori</creatorcontrib><creatorcontrib>Fujikawa, Keiko</creatorcontrib><creatorcontrib>Sato, Hiroshi</creatorcontrib><creatorcontrib>Seiki, Motoharu</creatorcontrib><creatorcontrib>Ishii, Seiichi</creatorcontrib><creatorcontrib>Fujinaga, Kei</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watabe, Tetsuya</au><au>Yoshida, Koichi</au><au>Shindoh, Masanobu</au><au>Kaya, Mitsunori</au><au>Fujikawa, Keiko</au><au>Sato, Hiroshi</au><au>Seiki, Motoharu</au><au>Ishii, Seiichi</au><au>Fujinaga, Kei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1998-07-03</date><risdate>1998</risdate><volume>77</volume><issue>1</issue><spage>128</spage><epage>137</epage><pages>128-137</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Urokinase plasminogen activator (uPA) has been associated with invasion and metastasis in breast cancer. The expression of uPA and 92 kDa type IV collagenase (gelatinase B/MMP‐9) is regulated by growth factors, receptor‐type tyrosine kinases and cytoplasmic oncoproteins. Here, we have identified transcriptional requirements for the induction of uPA and 92 kDa type IV collagenase by epidermal growth factor (EGF). EGF stimulates the motile and invasive activities specifically in the ErbB‐2‐overexpressing SK‐BR‐3 cells. Expression of extracellular matrix‐degrading proteases including type I collagenase/MMP‐1, 92 kDa type IV collagenase/MMP‐9, uPA and uPA receptor were induced. EGF also transiently stimulated expression of the transcription factors Ets‐1 and Ets‐2. Reporter transfection assays revealed the activation of uPA and MMP‐9 collagenase promoters by EGF and the requirement of each of the composite Ets and AP‐1 transcription factor binding sites for an EGF response. Most notably, transfections with the Ets‐1 and Ets‐2 expression vectors potentiated uPA and MMP‐9 promoter activation in response to EGF. Mutation of the threonine 75 residue of chicken Ets‐2 conserved in the Pointed group of the Ets family proteins abrogated the ability of Ets‐2 to collaborate with EGF. Ets‐1 and Ets‐2 were highly expressed in invasive breast tumor cell lines. Our results suggest that Ets‐1 and Ets‐2 provide the link connecting EGF stimuli with activation of uPA and 92 kDa type IV collagenase promoters and may contribute to invasion phenotypes. Int. J. Cancer 77:128–137, 1998.© 1998 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>9639404</pmid><doi>10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0020-7136 |
ispartof | International journal of cancer, 1998-07, Vol.77 (1), p.128-137 |
issn | 0020-7136 1097-0215 |
language | eng |
recordid | cdi_proquest_miscellaneous_79950316 |
source | Wiley-Blackwell Journals; MEDLINE; EZB Electronic Journals Library |
subjects | Biological and medical sciences Breast Neoplasms - genetics Breast Neoplasms - pathology Collagenases - genetics Dissemination DNA-Binding Proteins Epidermal Growth Factor - pharmacology Female Gene Expression Regulation, Neoplastic - drug effects Humans Medical sciences Neoplasm Invasiveness Promoter Regions, Genetic Proto-Oncogene Protein c-ets-1 Proto-Oncogene Protein c-ets-2 Proto-Oncogene Proteins - genetics Proto-Oncogene Proteins c-ets Repressor Proteins Trans-Activators - genetics Transcription Factors - genetics Tumor cell Tumor Cells, Cultured Tumors Urokinase-Type Plasminogen Activator - genetics |
title | The Ets‐1 and Ets‐2 transcription factors activate the promoters for invasion‐associated urokinase and collagenase genes in response to epidermal growth factor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T15%3A04%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Ets%E2%80%901%20and%20Ets%E2%80%902%20transcription%20factors%20activate%20the%20promoters%20for%20invasion%E2%80%90associated%20urokinase%20and%20collagenase%20genes%20in%20response%20to%20epidermal%20growth%20factor&rft.jtitle=International%20journal%20of%20cancer&rft.au=Watabe,%20Tetsuya&rft.date=1998-07-03&rft.volume=77&rft.issue=1&rft.spage=128&rft.epage=137&rft.pages=128-137&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19980703)77:1%3C128::AID-IJC20%3E3.0.CO;2-9&rft_dat=%3Cproquest_cross%3E79950316%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79950316&rft_id=info:pmid/9639404&rfr_iscdi=true |